The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Latchman, Y.
Right arrow Articles by Reiser, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Latchman, Y.
Right arrow Articles by Reiser, H.
The Journal of Immunology, 1998, 161: 5809-5812.
Copyright © 1998 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Identification of the 2B4 Molecule as a Counter-Receptor for CD481

Yvette Latchman, Paul F. McKay and Hans Reiser2

Department of Immunology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

The CD48 molecule belongs to a subfamily of the Ig superfamily that also includes the CD2, CD58, 2B4, Signaling lymphocyte activation molecule (SLAM), and Ly-9 molecules. Receptor-ligand interactions are known to occur between several members of this family, and these interactions can strengthen cell to cell adhesion. In mice, the CD48 molecule can bind to CD2. To search for additional ligands of murine CD48, we have generated a chimeric fusion protein consisting of the extracellular domain of murine CD48 and the C region of human IgG1. The results of immunofluorescence and immunoprecipitation experiments in which this reagent was used identify the 2B4 molecule as a novel counter-receptor of CD48.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. K. Chlewicki, C. A. Velikovsky, V. Balakrishnan, R. A. Mariuzza, and V. Kumar
Molecular Basis of the Dual Functions of 2B4 (CD244)
J. Immunol., June 15, 2008; 180(12): 8159 - 8167.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Wahle, K. H. T. Paraiso, R. D. Kendig, H. R. Lawrence, L. Chen, J. Wu, and W. G. Kerr
Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell
J. Immunol., December 15, 2007; 179(12): 8009 - 8015.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Vacca, G. Pietra, M. Falco, E. Romeo, C. Bottino, F. Bellora, F. Prefumo, E. Fulcheri, P. L. Venturini, M. Costa, et al.
Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function
Blood, December 15, 2006; 108(13): 4078 - 4085.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Bhat, P. Eissmann, J. Endt, S. Hoffmann, and C. Watzl
Fine-tuning of immune responses by SLAM-related receptors
J. Leukoc. Biol., March 1, 2006; 79(3): 417 - 424.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y. T. Bryceson, M. E. March, D. F. Barber, H.-G. Ljunggren, and E. O. Long
Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells
J. Exp. Med., October 3, 2005; 202(7): 1001 - 1012.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Assarsson, T. Kambayashi, C. M. Persson, B. J. Chambers, and H.-G. Ljunggren
2B4/CD48-Mediated Regulation of Lymphocyte Activation and Function
J. Immunol., August 15, 2005; 175(4): 2045 - 2049.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Martin, J. M. Del Valle, I. Saborit, and P. Engel
Identification of Grb2 As a Novel Binding Partner of the Signaling Lymphocytic Activation Molecule-Associated Protein Binding Receptor CD229
J. Immunol., May 15, 2005; 174(10): 5977 - 5986.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. V. Vaidya, S. E. Stepp, M. E. McNerney, J.-K. Lee, M. Bennett, K.-M. Lee, C. L. Stewart, V. Kumar, and P. A. Mathew
Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells
J. Immunol., January 15, 2005; 174(2): 800 - 807.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Munitz, I. Bachelet, S. Fraenkel, G. Katz, O. Mandelboim, H.-U. Simon, L. Moretta, M. Colonna, and F. Levi-Schaffer
2B4 (CD244) Is Expressed and Functional on Human Eosinophils
J. Immunol., January 1, 2005; 174(1): 110 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Mooney, J. Klem, C. Wulfing, L. A. Mijares, P. L. Schwartzberg, M. Bennett, and J. D. Schatzle
The Murine NK Receptor 2B4 (CD244) Exhibits Inhibitory Function Independent of Signaling Lymphocytic Activation Molecule-Associated Protein Expression
J. Immunol., September 15, 2004; 173(6): 3953 - 3961.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Chen, F. Relouzat, R. Roncagalli, A. Aoukaty, R. Tan, S. Latour, and A. Veillette
Molecular Dissection of 2B4 Signaling: Implications for Signal Transduction by SLAM-Related Receptors
Mol. Cell. Biol., June 15, 2004; 24(12): 5144 - 5156.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Flaig, S. Stark, and C. Watzl
Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction
J. Immunol., June 1, 2004; 172(11): 6524 - 6527.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K.-M. Lee, M. E. McNerney, S. E. Stepp, P. A. Mathew, J. D. Schatzle, M. Bennett, and V. Kumar
2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells
J. Exp. Med., May 3, 2004; 199(9): 1245 - 1254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Ferlazzo and C. Munz
NK Cell Compartments and Their Activation by Dendritic Cells
J. Immunol., February 1, 2004; 172(3): 1333 - 1339.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. Dhanji and H.-S. Teh
IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor Cells
J. Immunol., October 1, 2003; 171(7): 3442 - 3450.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Watzl and E. O. Long
Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts
J. Exp. Med., January 6, 2003; 197(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Howie, S. Okamoto, S. Rietdijk, K. Clarke, N. Wang, C. Gullo, J. P. Bruggeman, S. Manning, A. J. Coyle, E. Greenfield, et al.
The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon gamma production
Blood, September 26, 2002; 100(8): 2899 - 2907.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kambayashi, E. Assarsson, B. J. Chambers, and H.-G. Ljunggren
Cutting Edge: Regulation of CD8+ T Cell Proliferation by 2B4/CD48 Interactions
J. Immunol., December 15, 2001; 167(12): 6706 - 6710.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. S. Chuang, P. R. Kumaresan, and P. A. Mathew
2B4 (CD244)-Mediated Activation of Cytotoxicity and IFN-{gamma} Release in Human NK Cells Involves Distinct Pathways
J. Immunol., December 1, 2001; 167(11): 6210 - 6216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Martin, X. Romero, M. A. de la Fuente, V. Tovar, N. Zapater, E. Esplugues, P. Pizcueta, J. Bosch, and P. Engel
CD84 Functions as a Homophilic Adhesion Molecule and Enhances IFN-{gamma} Secretion: Adhesion Is Mediated by Ig-Like Domain 1
J. Immunol., October 1, 2001; 167(7): 3668 - 3676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. A. Kingsbury, L. A. Feeney, Y. Nong, S. A Calandra, C. J. Murphy, J. M. Corcoran, Y. Wang, M. R. Prabhu Das, S. J. Busfield, C. C. Fraser, et al.
Cloning, Expression, and Function of BLAME, a Novel Member of the CD2 Family
J. Immunol., May 1, 2001; 166(9): 5675 - 5680.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Sayos, K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst
Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4
Int. Immunol., December 1, 2000; 12(12): 1749 - 1757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Watzl, C. C. Stebbins, and E. O. Long
Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244)
J. Immunol., October 1, 2000; 165(7): 3545 - 3548.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Benoit, X. Wang, H. F. Pabst, J. Dutz, and R. Tan
Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease
J. Immunol., October 1, 2000; 165(7): 3549 - 3553.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Parolini, C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H. D. Ochs, H. Wolf, J.-Y. Bonnefoy, R. Biassoni, et al.
X-Linked Lymphoproliferative Disease: 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus-Infected Cells
J. Exp. Med., August 7, 2000; 192(3): 337 - 346.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Gonzalez-Cabrero, C. J. Wise, Y. Latchman, G. J. Freeman, A. H. Sharpe, and H. Reiser
CD48-deficient mice have a pronounced defect in CD4+ T cell activation
PNAS, February 2, 1999; 96(3): 1019 - 1023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Morra, M. Simarro-Grande, M. Martin, A. S.-I. Chen, A. Lanyi, O. Silander, S. Calpe, J. Davis, T. Pawson, M. J. Eck, et al.
Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients
J. Biol. Chem., September 21, 2001; 276(39): 36809 - 36816.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.